publication venue for
- Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations. 1160-1168. 2013
- Gene expression signatures predict outcome in non-muscle invasive bladder carcinoma ¿ a multi-center validation study. 3545-3551. 2007
- FGFR3 and TP53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis. 5444-5450. 2005